Cargando…

Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study

Epidemiological studies have reported a strong association between liver injury and incidences of hepatocellular carcinoma in sections of humans globally. Several preclinical studies have shown a strong link between cyanotoxin exposure and the development of nonalcoholic steatohepatitis, a precursor...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Punnag, Upright, Macayla, Bose, Dipro, Roy, Subhajit, Trivedi, Ayushi, More, Madhura, Scott, Geoff I., Brooks, Bryan W., Chatterjee, Saurabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785749/
https://www.ncbi.nlm.nih.gov/pubmed/36548732
http://dx.doi.org/10.3390/toxins14120835
_version_ 1784858124481462272
author Saha, Punnag
Upright, Macayla
Bose, Dipro
Roy, Subhajit
Trivedi, Ayushi
More, Madhura
Scott, Geoff I.
Brooks, Bryan W.
Chatterjee, Saurabh
author_facet Saha, Punnag
Upright, Macayla
Bose, Dipro
Roy, Subhajit
Trivedi, Ayushi
More, Madhura
Scott, Geoff I.
Brooks, Bryan W.
Chatterjee, Saurabh
author_sort Saha, Punnag
collection PubMed
description Epidemiological studies have reported a strong association between liver injury and incidences of hepatocellular carcinoma in sections of humans globally. Several preclinical studies have shown a strong link between cyanotoxin exposure and the development of nonalcoholic steatohepatitis, a precursor of hepatocellular carcinoma. Among the emerging threats from cyanotoxins, new evidence shows cylindrospermopsin release in freshwater lakes. A known hepatotoxin in higher concentrations, we examined the possible role of cylindrospermopsin in causing host gut dysbiosis and its association with liver pathology in a mouse model of toxico-pharmacokinetics and hepatic pathology. The results showed that oral exposure to cylindrospermopsin caused decreased diversity of gut bacteria phyla accompanied by an increased abundance of Clostridioides difficile and decreased abundance of probiotic flora such as Roseburia, Akkermanssia, and Bacteroides thetaiotamicron, a signature most often associated with intestinal and hepatic pathology and underlying gastrointestinal disease. The altered gut dysbiosis was also associated with increased Claudin2 protein in the intestinal lumen, a marker of gut leaching and endotoxemia. The study of liver pathology showed marked liver inflammation, the release of damage-associated molecular patterns, and activation of toll-like receptors, a hallmark of consistent and progressive liver damage. Hepatic pathology was also linked to increased Kupffer cell activation and stellate cell activation, markers of progressive liver damage often linked to the development of liver fibrosis and carcinoma. In conclusion, the present study provides additional evidence of cylindrospermopsin-linked progressive liver pathology that may be very well-linked to gut dysbiosis, though definitive evidence involving this link needs to be studied further.
format Online
Article
Text
id pubmed-9785749
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97857492022-12-24 Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study Saha, Punnag Upright, Macayla Bose, Dipro Roy, Subhajit Trivedi, Ayushi More, Madhura Scott, Geoff I. Brooks, Bryan W. Chatterjee, Saurabh Toxins (Basel) Article Epidemiological studies have reported a strong association between liver injury and incidences of hepatocellular carcinoma in sections of humans globally. Several preclinical studies have shown a strong link between cyanotoxin exposure and the development of nonalcoholic steatohepatitis, a precursor of hepatocellular carcinoma. Among the emerging threats from cyanotoxins, new evidence shows cylindrospermopsin release in freshwater lakes. A known hepatotoxin in higher concentrations, we examined the possible role of cylindrospermopsin in causing host gut dysbiosis and its association with liver pathology in a mouse model of toxico-pharmacokinetics and hepatic pathology. The results showed that oral exposure to cylindrospermopsin caused decreased diversity of gut bacteria phyla accompanied by an increased abundance of Clostridioides difficile and decreased abundance of probiotic flora such as Roseburia, Akkermanssia, and Bacteroides thetaiotamicron, a signature most often associated with intestinal and hepatic pathology and underlying gastrointestinal disease. The altered gut dysbiosis was also associated with increased Claudin2 protein in the intestinal lumen, a marker of gut leaching and endotoxemia. The study of liver pathology showed marked liver inflammation, the release of damage-associated molecular patterns, and activation of toll-like receptors, a hallmark of consistent and progressive liver damage. Hepatic pathology was also linked to increased Kupffer cell activation and stellate cell activation, markers of progressive liver damage often linked to the development of liver fibrosis and carcinoma. In conclusion, the present study provides additional evidence of cylindrospermopsin-linked progressive liver pathology that may be very well-linked to gut dysbiosis, though definitive evidence involving this link needs to be studied further. MDPI 2022-12-01 /pmc/articles/PMC9785749/ /pubmed/36548732 http://dx.doi.org/10.3390/toxins14120835 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Saha, Punnag
Upright, Macayla
Bose, Dipro
Roy, Subhajit
Trivedi, Ayushi
More, Madhura
Scott, Geoff I.
Brooks, Bryan W.
Chatterjee, Saurabh
Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study
title Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study
title_full Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study
title_fullStr Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study
title_full_unstemmed Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study
title_short Subchronic Oral Cylindrospermopsin Exposure Alters the Host Gut Microbiome and Is Associated with Progressive Hepatic Inflammation, Stellate Cell Activation, and Mild Fibrosis in a Preclinical Study
title_sort subchronic oral cylindrospermopsin exposure alters the host gut microbiome and is associated with progressive hepatic inflammation, stellate cell activation, and mild fibrosis in a preclinical study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785749/
https://www.ncbi.nlm.nih.gov/pubmed/36548732
http://dx.doi.org/10.3390/toxins14120835
work_keys_str_mv AT sahapunnag subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT uprightmacayla subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT bosedipro subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT roysubhajit subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT trivediayushi subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT moremadhura subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT scottgeoffi subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT brooksbryanw subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy
AT chatterjeesaurabh subchronicoralcylindrospermopsinexposurealtersthehostgutmicrobiomeandisassociatedwithprogressivehepaticinflammationstellatecellactivationandmildfibrosisinapreclinicalstudy